Senior Thought Leader Liaison — Neuromuscular

BioSpace; Kansas; Hybrid; USD 230,000 - 260,000; Full time

Job summary

Dyne Therapeutics seeks a Director, Thought Leader Liaison to build credible, compliant relationships with neuromuscular experts and advocates, translating insights into commercial strategy. This field-based role covers the Midwest TLL region, requiring extensive travel and strategic cross-functional collaboration.

Ideal candidates have 10+ years in biotech/pharma, with strong experience in rare diseases, and a proven ability to engage thought leaders in a commercial context while ensuring

Qualifications

• Bachelor's degree required; advanced degree preferred.
• 10+ years in biotechnology/pharmaceutical commercial roles, especially rare disease or specialty markets.
• Proven experience engaging neuromuscular or rare disease thought leaders in a commercial context.
• Strong understanding of the rare disease commercialization landscape and patient advocacy.
• Ability to translate science insights into actionable commercial strategies; self-starter with results.

Responsibilities

• Develops and executes a thought leader engagement strategy for rare neuromuscular diseases.
• Identifies and prioritizes national and regional neuromuscular thought leaders.
• Builds trust-based relationships with clinicians and experts in neuromuscular disorders.
• Leads advisory boards, speaker programs, and peer-to-peer education initiatives.

Skills

10+ years experience

Thought leader engagement

Cross-functional collaboration

Executive presence

Regulatory/compliance

Self-starter

Travel readiness

Education

Bachelor's degree

Advanced degree preferred

Job description

Dyne Therapeutics seeks a Director, Thought Leader Liaison to build credible, compliant relationships with neuromuscular experts and advocates, translating insights into commercial strategy. This field-based role covers the Midwest TLL region, requiring extensive travel and strategic cross-functional collaboration.

Ideal candidates have 10+ years in biotech/pharma, with strong experience in rare diseases, and a proven ability to engage thought leaders in a commercial context while ensuring